- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03745755
Derivation of a Clinical Decision Rule for Emergency Department Head CT Scanning in Seniors Who Have Fallen
July 21, 2023 updated by: McMaster University
Derivation of a Clinical Decision Rule for Emergency Department Head CT Scanning in Seniors Who Have Fallen (the Falls Multicentre Study)
Falls are the leading cause of traumatic death in the elderly with head injury causing half of these deaths.
Each year, one in three adults over the age of 65 (seniors) fall, and half of these seniors seek treatment at a hospital emergency department (ED).
There is a major evidence gap in the study of brain injury diagnosis in seniors, which is problematic for emergency physicians since the number of fall-associated head injuries is rising.
ED diagnostic tools for risk stratification of these patients do not exist.
The investigators will derive a novel ED clinical decision rule for detecting traumatic intracranial bleeding which will standardize the approach to head CT scans.
Once validated, the investigators will optimize patient care by ensuring that intracranial bleeding is identified early.
By reducing the use of head CT, this decision rule will lead to health care savings and streamlined, patient-centered ED care.
Study Overview
Status
Completed
Conditions
Detailed Description
This study is designed to develop a unique clinical decision rule for ED physicians evaluating senior patients who have fallen.
Clinical decision rules are a common method for standardizing diagnostic decision-making and minimizing misdiagnosis in the ED.
Each patient will be assessed at their index ED visit by an emergency physician who will record history and examination findings.
The primary outcome will be clinically important intracranial bleeding diagnosed with 42 days.
Patients who return to the ED within 42 days with new confusion, headache, loss of balance, repeat falls, change in behaviour, reduced Glasgow Coma Scale score or other neurological symptoms will also undergo head CT.
All intracranial bleeding events will be adjudicated independently.
Study Type
Observational
Enrollment (Actual)
4308
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Hamilton, Ontario, Canada
- Hamilton Health Sciences
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years and older (Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
ED patients aged over 65 years who present to the ED within 48 hours of having a fall. Eligibility is determined by having fallen on level ground (either inside or outside), off a chair or toilet seat or off a bed.
Patients are included regardless of whether they hit their head.
Description
Inclusion Criteria:
- 65+ years old
- Fall within 48 hours of emergency department visit (regardless of presenting complaint)
Exclusion Criteria:
- Repeat event/visit (already enrolled in the study)
- Transferred from another hospital
- Lives outside of hospital catchment area
- Major trauma (e.g. fall from steps, fall from height, motor vehicle accident, struck by a vehicle, recreational accident)
- Left emergency department prior to completion of assessment (left against medical advice)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinically important intracranial bleeding
Time Frame: Within 42 days of the index emergency department presentation.
|
Number of patients with bleeding within the cranial vault (including subdural, intracerebral, intraventricular, subarachnoid, epidural blood and cerebral contusion) which requires medical or surgical treatment.
|
Within 42 days of the index emergency department presentation.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Neurosurgical intervention
Time Frame: Within 90 days
|
Number of patients with intracranial bleeding who undergo neurosurgical intervention.
|
Within 90 days
|
Intensive care admission
Time Frame: Within 90 days
|
Number of patients with intracranial bleeding who are admitted to the intensive care unit.
|
Within 90 days
|
Hospital length of stay
Time Frame: Within 90 days
|
Duration of hospitalization among patients with intracranial bleeding.
|
Within 90 days
|
In-hospital death
Time Frame: Within 90 days
|
Number of patients with intracranial bleeding who die in hospital.
|
Within 90 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Kerstin de Wit, MD, McMaster University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 30, 2019
Primary Completion (Actual)
November 15, 2020
Study Completion (Actual)
July 20, 2023
Study Registration Dates
First Submitted
November 15, 2018
First Submitted That Met QC Criteria
November 16, 2018
First Posted (Actual)
November 19, 2018
Study Record Updates
Last Update Posted (Actual)
July 25, 2023
Last Update Submitted That Met QC Criteria
July 21, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Falls_MC_5304
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fall
-
University of AmsterdamCompletedDeprescribing | Fall | Fall Injury | Fall Patients | Accidental FallNetherlands
-
University of Illinois at Urbana-ChampaignUnknownFall Injury | Fall Prevention | Fall Safety
-
University of ArizonaVirginia Polytechnic Institute and State UniversityNot yet recruiting
-
Neuroscience Research AustraliaThe University of New South WalesCompleted
-
Aalborg University HospitalCompleted
-
Leon BrüllHumboldt-Universität zu BerlinTerminatedFall Risk, Fall PreventionGermany
-
Academisch Medisch Centrum - Universiteit van Amsterdam...VU University of AmsterdamNot yet recruitingFall | Aged | Fall Injury | Fall Patients | Polypharmacy | Accidental Fall | Aged, 80 and Over | DeprescriptionsNetherlands
-
Dalarna UniversitySormland County Council, SwedenRecruiting
-
University of PotsdamSwiss Council for Accident Prevention; Prof. Dr. Reto W. Kressig and Dr. Yves...CompletedFall Prevention | Fall Risk FactorsGermany
-
MedicusTek, IncCompletedPatient Fall | Accidental Fall From BedTaiwan